Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia

European Journal of Internal Medicine

Volumn 36, Issue , 2016, Pages 74-80

  Loffredo, Lorenzo ^a   Cangemi, Roberto ^a   Perri, Ludovica ^a   Catasca, Elisa ^a   Calvieri, Camilla ^a   Carnevale, Roberto ^a   Nocella, Cristina ^a   Equitani, Francesco ^b   Ferro, Domenico ^a   Violi, Francesco ^a   Battaglia, Simona ^a   Bertazzoni, Giuliano ^a   Biliotti, Elisa ^a   Bucci, Tommaso ^a   Calabrese, Cinzia Myriam ^a   Casciaro, Marco ^a   Celestini, Andrea ^a   De Angelis, Maurizio ^a   De Marzio, Paolo ^a   Esvan, Rozenn ^a   Falcone, Marco ^c   Fazi, Lucia ^a   Sulekova, Lucia Fontanelli ^a   Franchi, Cristiana ^a   Giordo, Laura ^a   Grieco, Stefania ^a   Manzini, Elisa ^a   Marinelli, Paolo ^c   Mordenti, Michela ^c   Morelli, Sergio ^a   Palange, Paolo ^c   Pastori, Daniele ^a   Pignatelli, Pasquale ^a   Capparuccia, Marco Rivano ^a   Romiti, Giulio Francesco ^a   Rossi, Elisabetta ^a   Ruscio, Eleonora ^a   Russo, Alessandro ^c   Scarpellini, Maria Gabriella ^a   Solimando, Luisa ^a   Taliani, Gloria ^a   Trapè, Stefano ^a   Toriello, Filippo ^a   more..

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SANTA MARIA GORETTI HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Flow mediated dilation; Infection; Oxidative stress; Pneumonia

Indexed keywords

C REACTIVE PROTEIN; ENDOTOXIN; ISOPROSTANE DERIVATIVE; NITRATE; NITRITE; LIPOPOLYSACCHARIDE; NITRIC ACID DERIVATIVE;

AGED; ARTERY DILATATION; ARTICLE; BLOOD FLOW; BRACHIAL ARTERY; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENDOTOXEMIA; FATTY ACID BLOOD LEVEL; FEMALE; FLOW-MEDIATED DILATION TEST; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PNEUMONIA SEVERITY INDEX; PROSPECTIVE STUDY; BLOOD; COMMUNITY ACQUIRED INFECTION; DIAGNOSTIC IMAGING; ECHOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PNEUMONIA; VASCULAR ENDOTHELIUM; VASODILATATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRACHIAL ARTERY; COMMUNITY-ACQUIRED INFECTIONS; ENDOTHELIUM, VASCULAR; FEMALE; HOSPITALIZATION; HUMANS; ISOPROSTANES; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NITRATES; NITRITES; OXIDATIVE STRESS; PNEUMONIA; PROSPECTIVE STUDIES; ULTRASONOGRAPHY; VASODILATION;

EID: 84992410660     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2016.09.008     Document Type: Article

References (36)

1. [1] McCabe, C., Kirchner, C., Zhang, H., Daley, J., Fisman, D.N., Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med 169 (2009), 1525–1531.
2. [2] Violi, F., Cangemi, R., Calvieri, C., Pneumonia, thrombosis and vascular disease. J Thromb Haemost 12 (2014), 1391–1400.
3. [3] Violi, F., Carnevale, R., Calvieri, C., Nocella, C., Falcone, M., Farcomeni, A., et al. Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia. Thorax, 2015.
4. [4] Nichol, K.L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., Iwane, M., Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 348 (2003), 1322–1332.
5. [5] Corrales-Medina, V.F., Musher, D.M., Shachkina, S., Chirinos, J.A., Acute pneumonia and the cardiovascular system. Lancet 381 (2013), 496–505.
6. [6] Cangemi, R., Casciaro, M., Rossi, E., Calvieri, C., Bucci, T., Calabrese, C.M., et al. Platelet activation is associated with myocardial infarction in patients with pneumonia. J Am Coll Cardiol 64 (2014), 1917–1925.
7. [7] Falcone, M., Russo, A., Cangemi, R., Farcomeni, A., Calvieri, C., Barilla, F., et al. Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin. J Am Heart Assoc, 4, 2015, e001595.
8. [8] Perri, L., Pastori, D., Pignatelli, P., Violi, F., Loffredo, L., Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients. Int J Cardiol 179 (2015), 139–143.
9. [9] Ras, R.T., Streppel, M.T., Draijer, R., Zock, P.L., Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol 168 (2013), 344–351.
10. [10] Falcone, M., Russo, A., Giannella, M., Cangemi, R., Scarpellini, M.G., Bertazzoni, G., et al. Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia. PLoS One, 10, 2015, e0119528.
11. [11] Aujesky, D., Fine, M.J., The pneumonia severity index: a decade after the initial derivation and validation. Clin Infect Dis 47:Suppl 3 (2008), S133–S139.
12. [12] Fine, M.J., Auble, T.E., Yealy, D.M., Hanusa, B.H., Weissfeld, L.A., Singer, D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336 (1997), 243–250.
13. [13] Bone, R.C., Balk, R.A., Cerra, F.B., Dellinger, R.P., Fein, A.M., Knaus, W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992), 1644–1655.
14. [14] Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, M., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33 (2012), 1635–1701.
15. [15] Rabe, K.F., Hurd, S., Anzueto, A., Barnes, P.J., Buist, S.A., Calverley, P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 (2007), 532–555.
16. [16] McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Bohm, M., Dickstein, K., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33 (2012), 1787–1847.
17. [17] Thygesen, K., Alpert, J.S., Jaffe, A.S., Simoons, M.L., Chaitman, B.R., White, H.D., et al. Third universal definition of myocardial infarction. Circulation 126 (2012), 2020–2035.
18. [18] Bondonno, C.P., Liu, A.H., Croft, K.D., Ward, N.C., Puddey, I.B., Woodman, R.J., et al. Short-term effects of a high nitrate diet on nitrate metabolism in healthy individuals. Nutrients 7 (2015), 1906–1915.
19. [19] Corretti, M.C., Anderson, T.J., Benjamin, E.J., Celermajer, D., Charbonneau, F., Creager, M.A., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002), 257–265.
20. [20] Loffredo, L., Marcoccia, A., Pignatelli, P., Andreozzi, P., Borgia, M.C., Cangemi, R., et al. Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J 28 (2007), 608–612.
21. [21] Cangemi, R., Calvieri, C., Falcone, M., Bucci, T., Bertazzoni, G., Scarpellini, M.G., et al. Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events. Am J Cardiol 116 (2015), 647–651.
22. [22] Corrales-Medina, V.F., Musher, D.M., Wells, G.A., Chirinos, J.A., Chen, L., Fine, M.J., Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 125 (2012), 773–781.
23. [23] Joannides, R., Haefeli, W.E., Linder, L., Richard, V., Bakkali, E.H., Thuillez, C., et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91 (1995), 1314–1319.
24. [24] Hingorani, A.D., Cross, J., Kharbanda, R.K., Mullen, M.J., Bhagat, K., Taylor, M., et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 102 (2000), 994–999.
25. [25] Clapp, B.R., Hirschfield, G.M., Storry, C., Gallimore, J.R., Stidwill, R.P., Singer, M., et al. Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 111 (2005), 1530–1536.
26. [26] Charakida, M., Donald, A.E., Terese, M., Leary, S., Halcox, J.P., Ness, A., et al. Endothelial dysfunction in childhood infection. Circulation 111 (2005), 1660–1665.
27. [27] Loffredo, L., Carnevale, R., Perri, L., Catasca, E., Augelletti, T., Cangemi, R., et al. NOX2-mediated arterial dysfunction in smokers: acute effect of dark chocolate. Heart 97 (2011), 1776–1781.
28. [28] Heiss, C., Lauer, T., Dejam, A., Kleinbongard, P., Hamada, S., Rassaf, T., et al. Plasma nitroso compounds are decreased in patients with endothelial dysfunction. J Am Coll Cardiol 47 (2006), 573–579.
29. [29] Violi, F., Marino, R., Milite, M.T., Loffredo, L., Nitric oxide and its role in lipid peroxidation. Diabetes Metab Res Rev 15 (1999), 283–288.
30. [30] Lundberg, J.O., Weitzberg, E., NO generation from nitrite and its role in vascular control. Arterioscler Thromb Vasc Biol 25 (2005), 915–922.
31. [31] Cangemi, R., Calvieri, C., Bucci, T., Carnevale, R., Casciaro, M., Rossi, E., et al. Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia?. Antioxid Redox Signal 20 (2014), 2949–2954.
32. [32] Pratico, D., Prostanoid and isoprostanoid pathways in atherogenesis. Atherosclerosis 201 (2008), 8–16.
33. [33] Pleiner, J., Mittermayer, F., Schaller, G., MacAllister, R.J., Wolzt, M., High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation 106 (2002), 1460–1464.
34. [34] Szabo, C., Day, B.J., Salzman, A.L., Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger. FEBS Lett 381 (1996), 82–86.
35. [35] Jain, S., Self, W.H., Wunderink, R.G., Fakhran, S., Balk, R., Bramley, A.M., et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373 (2015), 415–427.
36. [36] Cangemi, R., Pignatelli, P., Carnevale, R., Bartimoccia, S., Nocella, C., Falcone, M., et al. Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia. J Infect, 2016, 10.1016/j.jinf.2016.05.013.